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Abstract  
Better understanding of bone growth and regeneration mechanisms within periosteal tissues will 
improve understanding of bone physiology and pathology. Macrophage contributions to bone 
biology and repair have been established but specific investigation of periosteal macrophages has 
not been undertaken. We used an immunohistochemistry approach to characterise macrophages 
in growing murine bone and within activated periosteum induced in a mouse model of bone 
injury. Osteal tissue macrophages (osteomacs) and resident macrophages were distributed 
throughout resting periosteum. Tissues were collected from 4 week old mice and osteomacs were 
observed intimately associated with sites of periosteal diaphyseal and metaphyseal bone 
dynamics associated with normal growth. This included F4/80+Mac-2-/low osteomac association 
with extended tracks of bone formation (modeling) on diphyseal periosteal surfaces. While this 
recapitulated endosteal osteomac characteristics, there was subtle variance in the morphology and 
spatial organization of modelling-associated osteomacs, which likely reflects the greater 
structural complexity of periosteum. We also demonstrated that osteomacs, resident macrophages 
and inflammatory macrophages (F4/80+Mac-2hi) were associated with the complex bone 
dynamics occurring within the periosteum at the metaphyseal corticalization zone.  These 3 
macrophage subsets were also present within activated native periosteum after bone injury across 
a 9 day time course that spanned the inflammatory through remodeling bone healing phases. This 
included osteomac association with foci of endochondral ossification within the activated native 
periosteum. These observations confirm that osteomacs are key components of both osteal 
tissues, in spite of salient differences between endosteal and periosteal structure and that multiple 
macrophage subsets are involved in periosteal bone dynamics.  
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Introduction 
Macrophages have broad functional potential as a consequence of their heterogeneity, 
microenvironmental awareness and plasticity. To harness the potential of macrophage biology for 
improving human health, more refined characterisation of macrophage subsets in any given 
biological response is needed. We previously characterized the resident macrophages within 
bone, osteal tissue macrophages (osteomacs) with minimum identification criteria being 
F4/80+Mac-2-/low cells within 3 cell diameters of a bone surface 1,2. Osteomacs 1-8 and/or recruited 
inflammatory macrophages 4, 5, 9-13 can influence bone dynamic events, particularly bone forming 
osteoblast anabolic outcomes. Macrophages have also been shown to be associated with sites of 
pathologic bone loss including prosthetic joint loosening 14 and have been implicated in systemic 
bone loss in an animal model of osteoporosis 15. Better appreciation of the full breadth of 
macrophage subtypes associated with bone dynamics and their bone-specific functional potential 
is required. Here we focused on macrophage contributions to skeletal biology and repair 
specifically in the periosteum. 
The periosteum is a specialised connective tissue composed of a vascularized and 
innervated fibrous membrane that encapsulates bone. It has two layers: an outer fibrous capsule 
layer containing elastic connective tissue (including Sharpey’s fibres), fibroblasts and blood 
vessels; and, an inner cambium layer containing capillaries, nerves, pre-osteoblasts/bone lining 
cells, osteoblasts and undifferentiated mesenchymal stromal/stem cells (also referred to as 
periosteum-derived progenitor cells) 16, 17. Periosteal bone modeling is essential for long bone 
formation 17, 18 and also in bone accrual induced by mechanical loading 18, 19. In contrast, the 
resting endosteum is a single cell layer of predominantly mesenchymal cells (osteoprogenitors, 
committed bone lining cells and mature osteoblasts) lining the internal surface of bone and is in 
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direct contact with adjacent bone marrow and sinusoidal network 20. Endosteal composition and 
biology has been more thoroughly investigated compared to periosteum. These tissues can 
respond independently and often differently to the same stimuli (review in ref. 18). Progenitor 
cells within the endosteum and periosteum have different potential: endosteal progenitors are 
restricted to osteoblastic differentiation but periosteal progenitors have osteoblastic and 
chondrocytic bi-potential 21. Therefore while many physiological bone dynamic processes occur 
in both endosteum and periosteum, they are distinct environments with varying biological 
mechanisms and outcomes.  
We have reported that both resting endosteum and periosteum contain osteomacs 1. We 
have provided detailed in situ characterization of osteomacs in both resting and active endosteal 
surfaces and provided insight into their bone-specific functions 1, 2, 22, 23. We have not reported 
detailed characterization of periosteal osteomacs. Given the clear variance in tissue structure, cell 
constituency and osteochondroprogenitor cell characteristics 18, it is important to independently 
characterise periosteal osteomacs and their distribution.   
The regenerative potential of periosteum is well described 16, 17, 21, 24 and this has been 
taken advantage of in many orthopaedic procedures (review in ref. 16). Given it is the major 
source of osteochondroprogenitor cells during fracture repair 21, 25, the regenerative potential of 
periosteum has been primarily assigned to these resident mesenchymal progenitor cells, with 
little consideration of the potential involvement of macrophages in this process 26, 27. During 
normal fracture healing chondrogenesis and subsequently soft callus formation initiates within de 
novo granulation tissue that originates from the hematoma 4, 28. The osteochondrogenic 
progenitors that are recruited to the hematoma-derived granulation tissue are likely sourced from 
the adjacent periosteum, that undergoes a proliferative response to the injury, and bone marrow 
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28. If formation of a hematoma is disrupted/delayed, successful bone repair still proceeds, but the 
anabolic response instead initiates within the fracture adjacent native periosteum 28. Therefore 
understanding cellular mechanisms within native periosteum, as well as the de novo granulation 
tissue, will also be important for understanding bone repair and likely be more relevant in 
stress/hairline fracture 19, 29, periostitis and/or stabilized non-displaced simple fractures that often 
fail to cause hematoma formation. Anabolic initiation within the native periosteum may also 
participate in low energy fragility fracture healing 30.  
In this study we characterized periosteal osteomacs and investigated the distribution of 
inflammatory versus resident macrophages, including osteomacs, within both naïve and inflamed 
periosteum using an established model of cortical bone healing (tibial injury model)31. The 
specific advantages of the tibial injury model is that it is minimally invasive (periosteum, 
endosteum and bone marrow left predominantly intact) 3, 31, 32 and therefore periosteal granulation 
tissue formation does not predominate the repair mechanism. 
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RESULTS 
Periosteum in actively growing mice contains both osteomacs and resident macrophages  
The distribution of long bone periosteal macrophages was examined in naïve, actively 
growing 4 wk old C57Bl/6 mice, with anti-F4/80 and anti-Mac-2 IHC performed in serial 
sections. The F4/80 antigen is a robust pan-macrophage marker in mouse tissues that is not 
expressed by osteoclasts 33, 34. Mac-2 expression is indicative of activated/inflammatory 
macrophages 35, it is also expressed in osteoclasts 36 and chondrocytes 37. Osteomacs were 
identified using our previously designated criteria: F4/80+Mac-2-/low cells within 3 cells diameter 
of a bone surface 1, 38. A comprehensive description of mouse long bones together with 
anatomical localization of different regions is presented in Supplemental Figure 1. 
In actively growing bone, periosteal accrual on cortical diaphyseal bone surfaces occurs 
via bone modeling. This was easily identified in the actively growing 4 wk old bone using the 
mature osteoblast marker osteocalcin (Figure 1A). In a near serial section stained for F4/80 
expression, numerous ramified osteomacs were observed intercalated within the mature 
osteoblasts (Figure 1B, arrows). This integrated patchwork pattern varied from osteomac 
distribution as sites of endosteal bone modeling where they have a more elongated morphology 
and form a more continuous canopy structure 1.  These modeling site-associated periosteal 
osteomacs were F4/80+Mac-2-/low (Figure 1C & D), recapitulating their endosteal counterparts 1. 
Periosteal osteomac/macrophage frequency was reduced in skeletally mature bone (10 wk old), 
particularly in the diaphyseal region (data not shown), which occurred in conjunction with 
previously reported age associated periosteal atrophy 30.  
F4/80+ macrophages were also intercalated within metaphyseal periosteum, which is 
considerably thicker than diaphyseal periosteum particularly in actively growing bone 30. The 
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metaphyseal corticalization zone during bone growth is a highly dynamic site with bone 
catabolism, modeling and remodeling occurring simultaneously in a focused anatomical location. 
Within the periosteum adjacent to the corticalization zone, F4/80+ macrophages were present in 
both the cambium and fibrous capsule layers (Figures 1E and G). Large ramified F4/80+Mac-2-
/low macrophages meeting the anatomical osteomac criteria were present in the cambium tissue 
close to the bone surface (Figure 1G and H, boxes). In addition to these bonafide osteomacs, two 
distinct resident macrophage populations were also identified. F4/80+Mac-2-/low resident 
macrophages that were not anatomically adjacent to bone (Figure 1E-H, black arrows) and 
F4/80+Mac-2high activated macrophages (Figure 1E-H, grey arrows) resided in the outer cambium 
and capsule tissues. Co-localization of F4/80 and Mac-2 within periosteal activated macrophages 
in the corticalization zone was confirmed by double immunofluorescence staining (Figure 2 A-
E). 
It is assumed that these inflammatory macrophages have been activated as a consequence 
of aseptic mechanisms associated with bone growth including upregulation of ‘pro-inflammatory’ 
cytokines such as tumour necrosis factor 39. Expression of Ly6C, an antigen associated with 
recruited inflammatory monocytes 40, was also examined in the naïve periosteum of 4 wk old 
mice and the vast majority of osteomacs/macrophages within periosteum did not express this 
marker (data not shown). Therefore metaphyseal periosteum contains both definitive osteomacs 
and at least two other resident macrophage populations. 
Periosteal macrophage frequency was determined using flow cytometry assessment of 
periosteal single cell preparations that were isolated using and rapid enzyme free method to avoid 
enzyme-mediate antigen shedding. Successful isolation of periosteal cells was confirmed by 20 
fold enrichment of CD45-CD31-CD51+ osteoblast in endosteal preparations compared to bone 
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marrow from contralateral limbs (p < 0.002, not shown). The percent frequency of F4/80+Ly6G- 
macrophages was similar in periosteum (average 14%) and bone marrow (average 17%) 
preparations (Figure 2F), which is similar to the 16% macrophage frequency previously 
demonstrated in neonatal calvarial cell preparations 1. Based on immunohistology examination 
above, osteomacs represent the largest portion or macrophages in the periosteal cell preparation.  
Osteomacs, resident and inflammatory macrophages are present in inflamed periosteal 
tissue during the anabolic phase of bone healing in vivo.  
The distribution of macrophages, including osteomacs, within the periosteum during a 
bone healing time course in a tibial injury model was investigated 3, 31. This fully stabilized bone 
injury heals predominantly via intramembranous ossification forming an intra-medullar and inter-
cortical bone bridge. It proceeds through standard repair stages of: inflammation phase (days 1 to 
3), anabolic modeling phase (days 4 to 7), and a catabolic modeling/remodeling phase (days 8 to 
12). It also induces a conservative periosteal anabolic reaction associated with the injury site, but 
does not proceed to periosteal bridging by a callus. The advantage of this model is that it only 
causes focal damage to the periosteum providing an opportunity to examine repair responses 
within the existing periosteum, which was identified by the presence of an intact fibrous capsule 
layer and clear presence of periosteal cambium layer.  
During the early stages of anabolic repair 5 days post-surgery, gross morphological 
assessment showed granulation tissue had formed immediately above the injury site and was 
continuous with tissue meeting the description of native periosteum (Figure 2A, boxed area). The 
granulation tissue-inflamed periosteum transition occurred on average 500µm from either side of 
the cortical edge of the bone injury site. The injury-associated inflamed diaphyseal periosteum 
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was expanded (Figure 2) compared to resting periosteum (Figure 1C and 41). This expansion was 
due to both inflammatory cell infiltrate and an increase in fibroblast and stromal-like cells (Figure 
2). The inflamed periosteum contained three morphologically distinct strata: a cambium layer 
directly adjacent to bone surface; a superficial capsule layer; and, an inflammatory layer, situated 
between the cambium and the capsule (Figure 2B-F). Numerous F4/80+ cells were distributed 
throughout all 3 periosteal layers (Figure 2A and B), and many of the F4/80+ cells within the 
cambium were osteomacs (F4/80+Mac-2-/low; Figure 2B and C, arrows). The cambium also 
contained a small population of F4/80+Mac-2high inflammatory macrophages (Figure 2B and C, 
boxed area). Few, if any of the F4/80+ osteomacs/macrophages within the cambium expressed 
Ly6C (Figure 2D). The cambium robustly stained for type 1 collagen (Col1a1) with the majority 
of cells and extracellular matrix within this layer positively stained (Figure 2E). Expression of 
Col1a1 clearly demarked the cambium from the other layers (Figure 2B-F) and suggests that this 
layer is directly participating in the fibrous repair process.  
The inflammatory layer of the expanded periosteum integrated directly with granulation 
tissue and contained F4/80+Mac-2high inflammatory macrophages (Figure 2B and C, circled area). 
These inflammatory macrophages were absent from the capsule (Figure 2B and C, grey arrows).  
The inflamed periosteum capsule macrophages were predominantly F4/80+Mac-2-/lowLy6C+ 
(Figure 2B, C and D, grey arrows). A subset of macrophages with the same marker profile was 
also observed in the inflammatory layer (Figure 2B, C and D). The majority of cells within the 
capsule layer were Ly6C+ (Figure 2D), including intercalated macrophages (Figure 2B-D, grey 
arrows), which was not observed in resting periosteum (data not shown). Overall, both osteomacs 
and inflammatory macrophages were prominent cellular components of the periosteal repair 
response throughout bone healing. 
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During late stage anabolic repair 7 days post-injury, the periosteal tissue associated with 
the injury zone remained expanded (Figure 3) compared to naïve diaphyseal periosteum (Figure 
1). Numerous F4/80+ macrophages were present throughout the inflamed periosteum (Figure 3A, 
boxed area). Toluidine blue staining confirmed lack of proteoglycan rich cartilage and 
accordingly absence of endochondral callus formation (Figure 3B). Unlike day 5 post injury, the 
discrete inflammatory strata had resolved, leaving the 2 physiologic periosteal layers, which 
continued to be considerably thicker (Figure 3) than naive periosteum (Figure 1). F4/80+Mac-2-
/low osteomacs were located within the periosteal cambium layer and did not express Ly6C 
(Figure 3C, D and E, black arrows). There were a smaller number of F4/80+Mac-2+/high 
inflammatory macrophages present within the periosteal cambium (Figure 3C and D, boxed 
area). F4/80+Mac-2+/high inflammatory macrophages were also within the sub-capsular area of the 
fibrous capsule (Figure 3C and D, circled area).  Small numbers of F4/80+Mac-2-/lowLy6C+ 
macrophages were still present in the superficial capsule (Figure 3C, D and E, grey arrows), 
although much lower levels of Ly6C antigen were expressed compared to day 5 (Figure 2). 
Col1a1 deposition was present throughout most of the periosteum at this time point although 
there was a clear gradient with higher expression closer to the cortical bone surface (Figure 3F). 
Interestingly at day 5 post surgery the capsule layer was negative for Col1a1 expression (Figure 
2E). Col1a1 expression in the capsule layer coincided with capsule infiltration of F4/80+Mac2-
/lowLy6Cneg resident macrophages (Figure 3). 
 
Periosteal endochondral ossification was a late event occurring at the juncture of the wound 
induced granulation tissue and expanded endogenous periosteum.  
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At 9 days post-surgery the remodeling phase had initiated as evidenced by early stage 
excavation of the intramedullary bone bridge (Figure 4A and 3). In many samples characteristics 
of the injury associated periosteum recapitulated those reported above for 7 days post-surgery 
(Figure 3). Toluidine blue staining combined with morphological features confirmed the presence 
of proteoglycan rich soft callus (Figure 4B, asterisk). Various stages of de novo bone formation 
were associated with the cartilage foci (Figure 4B and C, asterisk), from Col1a1 dense 
proteoglycan rich immature bone matrix (Figure 4B and C, circled areas) through to mature new 
bone (Figure 4B and C, crosshatch) that had been laid down on the original cortical surface 
(delineated by basophilic cement line in bone, Figure 4B, arrows). This pattern of matrix 
distribution supports that a conservative localized anabolic endochondral ossification response is 
induced within activated periosteum in this tibial injury model.  
F4/80+Mac-2-/low osteomacs were associated with new woven bone surfaces and 
particularly the immature Col1a1+ matrix (Figure 4D and E, black arrows). However, many of the 
F4/80+ cells in close proximity to these new bone surfaces co-expressed Mac-2 (Figure 4C-E, 
boxed area) and therefore it is unclear if they are osteomacs (osteomacs are Mac-2- under 
physiologic conditions) that have become ‘activated’ or if they are inflammatory macrophages. 
F4/80+Mac-2+/high inflammatory macrophages (Figure 4D and E, circled area) were also present 
within the cambium layer but predominantly restricted to Col1a1 low regions (Figure 4C-E). 
F4/80+Mac-2-/lowLy6C+ macrophages (Figure 4D, E and F, grey arrows) were present in the 
capsule region (Figure 4D, E and F, grey arrows). Ly6C can also be expressed by endothelial 
cells 42 and Ly6C+ cells were observed associated with a blood vessel bordering the cambium and 
capsule strata (Figure 4F). Overall multiple macrophage subsets are associated with anabolic foci 
within activated periosteum induced by bone injury. 
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DISCUSSION 
A comprehensive characterization of periosteal cellular composition is needed to improve 
knowledge of growth-associated, adaptive and pathological bone dynamics as well as bone 
repair/regeneration18. Herein we definitively demonstrate that osteomacs and resident 
macrophages are distributed throughout resting periosteum. Osteomacs also intimately associate 
with sites of periosteal diaphyseal and metaphyseal bone modeling during normal growth. 
Periosteal osteomacs had a similar expression profile to endosteal osteomacs (F4/80+Mac-2-
/lowLy6C+/-) 1, 23, however their morphology and spatial organization varied subtly, which likely 
reflects the greater structural complexity of periosteum compared to endosteum.  These 
observations confirm that osteomacs are key components of both osteal tissues, in spite of salient 
differences between endosteal and periosteal structure and adjacent environments. We also 
demonstrated that osteomacs (F4/80+Mac-2-/lowLy6C+/- cell within 3 cell diameters of bone 
surface), resident macrophages (F4/80+Mac-2-/lowLy6C+/- cell greater than 3 cell diameters of 
bone surface) and inflammatory macrophages (F4/80+Mac-2hi) were prominent cells within 
activated native periosteum after bone injury across a 9 day time course that spanned the 
inflammatory through remodeling healing phases. This included osteomac association with foci 
of endochondral ossification within the activated native periosteum.  
Interestingly, osteomacs/resident macrophages were the prominent, but not exclusive, 
macrophage subtype in areas of high Col1a1 deposition in activated native periosteum induced 
by bone injury. Macrophage induction of collagen deposition, particularly during wound healing 
and fibrotic responses, is well documented 43. Inflammatory macrophages potentially directly 
influence collagen deposition via expression of Mac-2 and, as Mac-2 can be secreted, their 
location within the immediate site of collagen deposition is not required 44. The distribution of 
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Col1a1 staining within the cambium even raised the possibility that osteomacs and inflammatory 
macrophages within this tissue were actually expressing Col1a1, which was somewhat surprising 
but not unprecedented 45, 46. Therefore, one of the functional contributions of osteomacs and other 
macrophage subsets within periosteum is likely stimulation of collagen deposition by 
mesenchymal cells, independent of whether they are osteoblasts or fibroblasts. 
The presence of multiple macrophage subsets within active native periosteum induced by 
bone injury provides further weight to the necessity of more clear distinction between the 
independent functional roles of distinct macrophages subsets during bone growth and 
repair/regeneration. Macrophage functional transition has been suggested to be a key mechanism 
orchestrating appropriate progression through the multiple phases of repair in soft tissue wound 
healing 43. We would predict that macrophage contributions would be even more intricate during 
the greater biological complexity involved in bone regeneration/healing. This is also supported 
by our description of resident and inflammatory macrophage site and phase specific distribution 
within granulation tissue during both intramembranous 3 or endochondral mediated bone repair 4. 
The dynamic growth events at the metaphyseal corticalization zone also exhibited complexity in 
periosteal macrophage diversity during normal growth. This suggests that the highly specialized 
developmental events occurring within this dynamic site, which involves both bone formation 
and resorption acting in concert, requires diverse functional support from multiple specialized 
macrophage subsets.  
Broad spectrum macrophage depletion resulted in rapid and striking loss of endosteal 
osteoblast surface and osteoblast-mediated bone formation 1, 2, 5, 6 and resulted in failed bone 
healing 3, 4. Effort now needs to be focused on utilizing/developing more refined macrophage 
subset targeting approaches so a clear map of specific macrophage subset contributions can be 
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generated. Interestingly, in the tibial injury model exogenous CSF-1 induced selective expansion 
of osteomacs within the intra-medullar woven bone bridge and subsequently enhanced Col1a1 
deposition at this site 3. This provides evidence that even a broad spectrum pro-macrophage 
molecule can achieve subset specific outcomes and consequently have targeted and positive 
impact on bone repair.  
A clear outcome of the current study is that osteomacs/macrophages are located at sites of 
periosteal anabolism and therefore it is likely that they contribute to the regenerative properties of 
periosteum. This needs to be confirmed by further investigation. Macrophage contributions to 
this regenerative potential have been considered for bone tissue engineering approaches 26, 27. 
However, given the pleiotropic nature of macrophages, achieving appropriate and consistent 
promotion of macrophage trophic support of mesenchymal stem and progenitor cells, pro-
angiogenic, chemotactic and regenerative cytokine/growth factor production versus inducing 
destructive/foreign body macrophage reactions may prove therapeutically challenging 26, 27. 
Achieving the appropriate macrophage functional balance will be aided by fine mapping of 
macrophage subset specific contributions to periosteal anabolic and catabolic events and 
dissection of the molecules coordinating these outcomes. Our study also supports the previous 
suggestion 28 that anabolic events can initiate in the activated native periosteum adjacent to a 
fracture site. This suggests that fracture adjacent periosteum is a viable target organ for reigniting 
failed fracture repair and that promoting osteomacs/macrophages may be integral to achieving 
this approach.  
This study confirms that osteomac/macrophage participation during bone homeostasis and 
anabolism, independent of the anabolic mechanism, are likely consistent in all osteal tissues. As 
we have also previously reported osteomac presence in calvarial osteal tissue 1 and others have 
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shown macrophage contributions to calvarial injury repair, this cellular mechanism applies to 
both flat and long bones. Our evidence that osteomacs are present in human osteal tissues 1, 47 
provides support that this biology isn’t a species specific phenomenon. Definitive dissection of 
the specific roles of macrophages and osteoblasts in bone formation and repair was recently 
revealed to be more challenging than traditionally appreciated as macrophage can be resistant to 
lethal doses of irradiation 48. Therefore chimeric models are unlikely to conclusively distinguish 
macrophage versus mesenchymal contributions to bone biology or repair. Careful validation of 
osteoblast restricted promoter expression models is also required as our current and previous 44, 45 
data suggest that macrophages can express Col1a1 45, 46. Overall the impact of 
osteomac/macrophage contributions needs to be carefully and appropriately considered during 
investigations of bone biology and bone repair.  
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METHODS 
Animals 
Animal experiments were undertaken as dictated by the Australian code for the care and 
use of animals for scientific purposes. The University of Queensland Molecular Biosciences 
and/or Health Sciences Ethics Committees approved all protocols involving animals. C57Bl/6 
male mice were supplied from Australian Resource Centre (Canning Vale, WA, Australia) and 
MacGreen mice (express green fluorescent protein (GFP) transgene under the control of the cfms 
promoter resulting in expression in mature myeloid lineage cells including macrophages 49 were 
sourced from an in-house breeding colony. Sample size was dictated by previous published data 
1,3,4 investigating macrophage contributions to bone biology and ethical considerations. No 
animals or samples were excluded from this study and were randomly allocated to different 
harvest points.  
 
Periosteal Cell Enrichment and Quantification of Osteomac Frequency 
Femora were harvested from 4-week old mixed gender MacGreen mice. Muscles 
surrounding the femora were removed by cutting the connective tissue from their attachment sites 
without scraping or damaging the periosteum. Epiphyseal bone ends were removed and central 
marrow was thoroughly flushed with 2% FBS/PBS using a 27G needle. Femora were cut in half 
longitudinally and the endosteal surface was gently flushed using a 19G needle and 2% FBS/PBS 
to dislodge any remaining endosteum and marrow. A periosteal enriched single cell suspension 
was generated using a gentle MACS Dissociator (Miltenyl Biotec, NSW, AU) as per 
manufacturer’s instructions. Cells were washed and resuspended in 2% FBS/PBS to generate a 
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single cell suspension. Bone marrow was flushed from contralateral limbs using a 2% FBS/PBS 
and a 27G needle. 
Bone marrow from the contralateral femur and periosteal cell preparation were blocked 
with 2% FCS/PBS. 1 x 106 bone marrow cells were incubated with myeloid or mesenchymal 
antibody cocktails for 40 minutes in ice on a rotary shaker. Myeloid antibody cocktail included 
anti-F4/80-Alexa647 (AbD Serotec, Kidlington, UK) and anti-Ly6G-PE/Cy7 (Biolegend). 
Mesenchymal antibody cocktail contained anti-Ter119-biotin (Biolegend), anti-CD31-BV605 
(Biolegend), CD45-APC/Cy7 (Biolegend) and anti-CD51-PE (Biolegend). Specificity of staining 
was determined by comparison to unstained cells and appropriate isotype control cocktails. Cells 
were then washed and resuspended in 2% FCS/PBS. 5 μg/mL 7-amino actinomycin D (Life 
technologies, CA, USA) was added 10 min before flow cytometry analysis to allow exclusion of 
dead cells. Analysis was performed on Beckman Coulter’s CyAn™ ADP Analyser (Beckman 
Coulter, Brea, CA). 300,000-1,000,000 events were collected and analysis performed on 
aggregate excluded, live cells using FlowJo software version 8.8.7 (Tree Star Data Analysis 
Software, Ashland, OR). Macrophages were gated as F4/80+Ly6G- cells (not shown). After 
exclusion of Ter119+ erythroid cells, osteoblasts were gated as CD45-CD31-CD51+ cells. 
 
Immunofluorescence Staining of Naive Bone Tissue 
Dual immunofluorescence staining was performed on deparaffinized and re-hydrated 
sections from 4-week old C57Bl/6 mice (n = 7) using sequential staining with the following 
reagents:  F4/80 (rat anti-mouse, Abcam, Cambridge, UK), goat anti-rat IgG F(ab’)2-biotin (Santa 
Cruz Biotechnology, CA), streptavidin conjugated-AlexaFluor647 (Thermo Fisher Scientific), 
Mac2 (rat anti-mouse) directly conjugated to AlexaFluor488, Biolegend, San Diego, CA). Nuclei 
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were counterstained with DAPI (4′,6-Diamidino-2-phenylindole dihydrochloride, Sigma Aldrich) 
and sections mounted with ProLong Gold mounting medium (Thermo Fisher Scientific). Slides 
were visualized using a Vectra-3 6-slide automated quantitative pathology imaging system 
(Perkin Elmer, Waltham, MA) and spectral unmixing performed using inForm software v2.2 
(Perkin Elmer). 
 
Statistical Analysis 
Data is represented as mean ± SEM, an unpaired students T-test was used to analysis flow 
cytometry data using PRISM 5 (Graph pad software) and a p value of <0.05 was considered 
statistically significant. 
 
Tibial bone injury model 
11-12 week old male C57Bl/6 mice were used in the cortical tibial injury model 31 surgery 
was performed as previously described 31.  
 
Tissue collection, processing and sectioning 
All left hind limbs were collected and processed as previously described 3 from either 
naive 4 or 10 weeks (wk) old mice or mice subjected to tibial injury 
 
Immunohistochemistry and histology 
Immunohistochemistry (IHC) was performed on deparaffinized and re-hydrated sections 
at 3 sectional depths as previously described 1 with specific primary antibodies: F4/80 (rat anti-
mouse, AbD Serotec, Kidlington, Oxford, UK), collagen type 1 (Col1a1; rabbit anti-mouse, US 
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Biological, Swampscott, MA), osteocalcin (rabbit anti-mouse, Alexix Biochemicals, San Diego, 
USA), Mac-2 (rat anti-mouse, eBioscience, San Diego, CA), and Ly6C (rat anti-mouse, Abcam, 
Cambridge, UK); or relevant isotype control antibodies (normal ratIgG2b (AbD Serotec), rat 
IgG2a (BD Bioscience Pharmingen, San Jose, CA) and normal rabbit IgG (Santa Cruz 
Biotechnology, Dallas, TX). All sections were counterstained using Mayer’s hematoxylin (Sigma 
Aldrich) and mounted using permanent mounting media (Thermo Fisher Scientific, Waltham, 
MA). Toludine blue staining was carried out as previously described 4. Tissue staining was 
viewed using a Nikon eclipse 80i microscope with a Nikon D5-Ri1 camera and NIS-elements 
imaging software version 3.1 (Nikon, Tokyo, Japan) or an Olympus BX50 microscope with an 
attached DP26 camera and imaged using Olympus CellSens standard 1.7 imaging software 
(Olympus, Japan).  
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Figure Legends 
Figure 1: Resident macrophages and osteomacs are present in the periosteum of growing 
bone.  
Representative images of periosteum in 4 wk C57Bl/6 murine long bone tissues (n = 5). All 
sections were counterstained with hematoxylin. A and B) IHC staining in near serial sections 
demonstrating that periosteal bone modeling tracks marked by osteocalcin+ (OCN) osteoblasts 
(A) contain frequently scattered F4/80+ osteomacs (B, black arrows). (C) F4/80+ osteomacs at 
diaphyseal periosteal modeling sites are Mac2-/low (D, black arrows). Serial section staining for 
F4/80 (E) or Mac-2 (F) expression demonstrated presence of multiple macrophage subsets in the 
periosteal metaphyseal corticolization zone.  (G & H) magnification of left aspect of images in E 
and F respectively showing F4/80+Mac-2-/low osteomacs (boxes), F4/80+Mac-2-/low  resident 
macrophages (black arrows) and F4/80+Mac-2high inflammatory macrophages (grey arrows). 
Original magnification: x40, with A, B, G and H digitally enlarged. CB (cortical bone). Scale bar 
indicates 50µm. 
 
Figure 2: Activated macrophages reside within the periosteal corticalizaiton zone and 
periosteal and BM macrophages have similar tissue population frequency.   
(A-E) Immunofluorescence double staining for F4/80 and Mac-2 expression in the periosteal 
corticalizaiton zone of 4-week old C57Bl/6 mice (n = 7). A) Pseudo-colouring of DAPI as 
haematoxylin counterstain and F4/80 staining as brown histology chromogen stain to provide 
anatomical context of corticalization zone. B-D) Immunofluorescence images with DAPI pseudo-
coloured blue, (B and D) F4/80 expression pseudo-coloured red and (C and D) Mac-2 expression 
pseudo-coloured green and colocalisation of staining detected as yellow-orange staining (D). A-
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D) Arrowheads indicate cells co-expressing F4/80 and Mac-2. E) Low power 
immunofluorescence image with DAPI pseudo-coloured white. Box indicates metaphyseal 
corticalization zone anatomical location of images shown in (A-D). A-D) Scale bar indicates 50 
µm and (E) scale bar indicates 300 µm. A-D) Original magnification x40 and (E) original 
magnification x10. F) Flow cytometry analysis of periosteal (Periost) and bone marrow (BM) 
single cell preparations (n = 13) from 4-week old MacGreen mice to determine percent F4/80+ 
macrophages in live cells as an indication of macrophage frequency within these resident tissues. 
Error bars represent standard deviations and there was no significant difference between the two 
cell preparations.  
 
Figure 3: Osteomacs and inflammatory macrophages are present within inflamed 
periosteum during the post-tibial injury early anabolic phase. 
Representative images of periosteal injury sites 5 days post-tibial injury in 12 wk C57Bl/6 mice 
(n = 5). All sections were counterstained with hematoxylin. Within the periosteal injury zone, 3 
distinct tissue layers were clearly evident based on morphological distinction: periosteal 
cambium (Cam), inflammatory (Inf) and capsule (Cap) layers. A) IHC staining with anti-F4/80 
antibody (brown) demonstrating numerous F4/80+ cells distributed throughout the periosteal 
injury zone. Panels B-F are higher magnification images taken of the boxed area shown in A, in 
the same or serial sections stained for (B) F4/80, (C) Mac-2, (D) Ly6C, (E) Col1a1 expression 
and (F) matched RatIgG2b isotype control. The crosshatches denote the same anatomical 
landmark in each image. Numerous F4/80+ osteomacs (B, black arrows) were present within the 
cambium were confirmed to express minimal to no expression of Mac-2 (C, black arrows). The 
cambium also contained F4/80+Mac-2+/high (B and C, box) inflammatory macrophages. 
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Expression of Ly6C in the cambium was minimal (D, black arrows). The inflammatory tissue 
contained numerous F4/80+Mac-2+/high inflammatory macrophages (B and C, circled area) but 
also contained a population of F4/80+Mac-2-/low resident macrophages, as there were more F4/80+ 
than Mac-2+ cells in this layer. The capsule tissue cells were predominantly Ly6C+ (D, grey 
arrows), some of which co-expressed F4/80 (B, grey arrows), but the capsule layer contained 
minimal to no Mac-2 staining (C, grey arrows). The cambium layer was Col1a1+ matrix enriched 
(E) with most cells in this layer expressing Col1a1+. Specificity of staining confirmed using both 
RatIgG2b (F) and Rabbit IgG matched isotype control (data not shown). Original magnification: 
A x4 and B-F x20. 
 
Figure 4: Macrophage, including osteomac distribution in periosteum during the post-tibial 
injury late anabolic phase.  
Representative images of periosteal injury sites 7 days post-tibial injury in 12week C57Bl/6 mice 
(n = 5). All sections were counterstained with hematoxylin. Both periosteal cambium (Cam) and 
capsule (Cap) layers were morphologically discernible. A) IHC staining with anti-F4/80 antibody 
(brown) demonstrating F4/80+ cells distributed throughout both periosteal layers. Panels B-F are 
higher magnification images taken of the boxed area shown in A, in serial sections stained with 
(B) Toluidine blue, (C) anti-F4/80, (D) anti-Mac-2, (E) anti-Ly6C and (F) anti-Col1a1 antibodies. 
The crosshatch denotes the same anatomical landmark in each image. Toluidine blue staining 
confirmed absence of endochondral ossification at the selected periosteal injury site (B). 
Numerous F4/80+ cells present within the cambium were confirmed to be osteomacs (C, black 
arrows) due to their proximity to the bone surface and minimal to no expression of Mac-2 (D, 
black arrows). The cambium also contained F4/80+ (C, box), Mac-2+ (D, box) inflammatory 
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macrophages. Periosteal expression of Ly6C was minimal and primarily limited to low level 
expression in the capsule layer (E, black arrows) and scattered Ly6C+ cells within the cambium 
with elongated endothelial morphology (E). The capsule layer contained numerous F4/80+ (C) 
Mac-2+ (D) inflammatory macrophages (circled area as example) and the superficial capsule 
contained a few cells F4/80+Mac-2negLy6C+ (C, D and E, grey arrows). Both cambium and 
capsule contained Col1a1+ matrix and cells with greater intensity of staining within the cambium 
(F). A and C-D were counterstained with hematoxylin. Original magnification: A x4 and B-F 
x20. 
 
Figure 5: Osteomacs and macrophages are associated with periosteal endochondral 
ossification foci induce after tibial injury. 
Representative images of endochondral ossification foci within periosteum 9 days post-tibial 
injury in 12 week C57Bl/6 mice (n = 5). A) IHC staining with anti-F4/80 antibody (brown) 
demonstrating F4/80+ cells distributed throughout the periosteal injury zone. Panels B-F are 
higher magnification images taken of the boxed area shown in A, in serial sections stained for (B) 
Toluidine blue, (C) anti-Col1a1, (D) anti-F4/80, (E) anti-Mac-2 and (F) anti-Ly6C antibodies. 
The marked blood vessel (BV) serves as an anatomical landmark in each of these images. B) A 
Small foci of endochondral ossification is present 9 days post-tibial injury as indicated by the 
presence of proteoglycan rich cartilage (purple, *).  Histological features also support that 
maturation of this cartilage to bone (cement line, arrows, with new bone above, light blue matrix 
marked with #) and adjacent proteoglycan rich osteoid (circles). C) This was confirmed to be new 
bone by staining for Col1a1 (brown), demonstrating intense staining for Col1a1 in the new bone 
(#) and immature osteoid (circles). Both F4/80+Mac-2-/low osteomacs (D, E arrows) and 
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F4/80+Mac-2+/highLy6C- inflammatory macrophages (D, E and F, boxed area) were observed 
adjacent to areas of new bone formation. The adjacent expanded periosteum contained numerous 
inflammatory F4/80+ (D) Mac-2+/high (E) macrophages (circled area as example), which expressed 
minimal-low Ly6C (F). The capsule layer contained scattered cells expressing F4/80, Mac-2 and 
Ly6C (D-F, grey arrows). A and C-D were counterstained with hematoxylin. Original 
magnification: A x4 and B-F x20. 





